Factors associated with receipt of mRNA-1273 vaccine at a United States national retail pharmacy during the COVID-19 pandemic-Reference-Cited by-同舟云学术

Factors associated with receipt of mRNA-1273 vaccine at a United States national retail pharmacy during the COVID-19 pandemic

Published:2023-06 Issue:29 Volume:41 Page:4257-4266
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Roberts-McCarthy Erin^ORCID,Buck Philip O.,Smith-Ray Renae L.^ORCID,Van de Velde Nicolas,Singh Tanya^ORCID,Mansi James,Shah Amy^ORCID,Taitel Michael

Funder

Moderna Inc

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference24 articles.

1. U.S. Food and Drug Administration. Spikevax and Moderna COVID-19 Vaccine; 2022. [online] Available at: [accessed 22 July 2022].

2. U.S. Food and Drug Administration. Comirnaty and Pfizer-BioNTech COVID-19 Vaccine; 2022. [online] Available at: [accessed 22 July 2022].

3. Centers for Disease Control and Prevention; 2022. [online] Available at: [accessed 22 July 2022].

4. Walgreens Boots Alliance. United States Segment; 2022. [online] Available at: [accessed 22 July 2022].

5. American Society of Health System Pharmacists. HHS Authorizes Pharmacy Technician and Pharmacy Intern Administration of COVID-19 Tests and Vaccines; 2022. [online] Available at: [accessed 22 July 2022].

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States;Nature Communications;2024-03-06

2. Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States;2023-07-12